APA
Massicotte M., Borget I., Broutin S., Baracos V. E., Leboulleux S., Baudin E., Paci A., Deroussent A., Schlumberger M. & Antoun S. (20130809). Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study. : The Journal of clinical endocrinology and metabolism.
Chicago
Massicotte Marie-Hélène, Borget Isabelle, Broutin Sophie, Baracos Vickie E, Leboulleux Sophie, Baudin Eric, Paci Angelo, Deroussent Alain, Schlumberger Martin and Antoun Sami. 20130809. Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study. : The Journal of clinical endocrinology and metabolism.
Harvard
Massicotte M., Borget I., Broutin S., Baracos V. E., Leboulleux S., Baudin E., Paci A., Deroussent A., Schlumberger M. and Antoun S. (20130809). Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study. : The Journal of clinical endocrinology and metabolism.
MLA
Massicotte Marie-Hélène, Borget Isabelle, Broutin Sophie, Baracos Vickie E, Leboulleux Sophie, Baudin Eric, Paci Angelo, Deroussent Alain, Schlumberger Martin and Antoun Sami. Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study. : The Journal of clinical endocrinology and metabolism. 20130809.